Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis (NASH) - a Prospective Open Label Phase I/II Trial

NCT01278056 is registered in ClinicalTrials.gov with Crolll Gmbh as lead sponsor.

NCT NCT01278056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01278056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis (NASH) - a Prospective Open Label Phase I/II Trial
Lead sponsor
Crolll Gmbh
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2010
Completion date
July 31, 2012
Enrollment
5 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

increased iron storage / disturbed distribution, non-alcoholic steatohepatitis